内容概要：化妆品原料是构成化妆品的基础，涵盖多种来源，决定产品功效与竞争力。近年来，随着消 费者对产品品质、成分安全与功效可靠性的要求日益提升，中国化妆品行业正从"高速增长"全面转 向"高质量发展"，2025年全渠道交易额达11042.45亿元。全球化妆品原料市场稳步增长，2024年规模已 达3592亿元，亚太地区尤其是中国市场成为增长核心。中国化妆品原料市场规模快速增长，2024年约为 650.04亿元，预计2026年达716.67亿元。其中，活性原料、植物提取原料和生物发酵原料市场规模均持 续扩大，生物发酵原料增速最快。企业竞争格局上，国际巨头主导高端市场，本土企业快速崛起，研发 创新成行业主旋律。未来，中国化妆品原料行业将以技术创新为核心，加速国产化替代，同时强化合规 绿色发展，向高质量、高创新、高合规方向稳步迈进。 上市企业：华熙生物（688363.SH）、贝泰妮（300957.SZ） 相关企业：山东福瑞达医药集团有限公司、浙江湃肽生物股份有限公司、北京东方淼森生物科技有限公 司、上海辉文生物技术股份有限公司、上海华伊美化妆品有限公司、山东安华生物医药股份有限公司、 吉林省健维天然生物科技有限公司、喜 ...

Investment Rating - The report indicates a positive outlook for the cosmetics raw materials industry, highlighting the stable growth of the downstream cosmetics sector and the leading positions of companies like Weiqi Technology and Jiakai Biological [1]. Core Insights - The cosmetics raw materials industry in China is projected to grow from CNY 1,147.80 billion in 2019 to CNY 1,603.90 billion by 2024, with a compound annual growth rate (CAGR) of 6.9% [2][12]. - The peptide active ingredients market is expected to grow from CNY 11.2 billion in 2019 to CNY 21.7 billion by 2024, achieving a CAGR of 14.1% [2][16]. - The plant extract raw materials market is anticipated to increase from CNY 204.5 billion in 2019 to CNY 270.2 billion by 2024, with a CAGR of 6.5% [2][20]. - Weiqi Technology holds a 6.6% market share in the peptide raw materials sector, ranking first in China [2][25]. - Jiakai Biological has established a leading position in the plant extract efficacy raw materials field, with significant revenue growth [2][33]. Summary by Sections 1. Growth of the Cosmetics Raw Materials Industry - The cosmetics raw materials market in China is expected to reach CNY 1,604 billion by 2024, driven by the stable growth of the cosmetics industry [2][5]. - The global cosmetics market is projected to reach USD 550.3 billion in 2024, with China being the largest market [5][8]. 2. Performance of Weiqi Technology and Jiakai Biological - Weiqi Technology's revenue for the first half of 2025 is CNY 132 million, a year-on-year increase of 34.6%, with a net profit of CNY 40.2 million, up 68.76% [2][30]. - Jiakai Biological's revenue for the first three quarters of 2025 is CNY 195 million, reflecting a year-on-year growth of 7.91%, with a net profit of CNY 47.3 million, up 16.91% [2][37]. 3. Market Trends and Valuation - The median price-to-earnings (P/E) ratio for the North Exchange consumer service sector increased to 50.1X, indicating a slight upward trend [2][50]. - The total market capitalization of consumer service companies on the North Exchange rose from CNY 1,096.29 billion to CNY 1,152.85 billion [2][43]. 4. Competitive Landscape - The cosmetics raw materials industry is characterized by a low concentration, with many small-scale companies primarily serving domestic mid-to-low-end markets [2][12]. - The demand for active ingredients, particularly peptides, is growing rapidly, driven by consumer preferences for effective skincare products [2][15].